samedan logo

 
 
spacer
home > pmps > summer 2007 > finding your voice
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Finding Your Voice

Greg Tanner of Vocollect Europe discusses the possibility of gaining better visibility in the pharmaceutical pipeline via voice systems

In recent years, the pharmaceutical industry has undergone vast transformation. Manufacturing innovation has led to a dramatic increase in the number and complexity of products. The regulatory landscape has changed beyond recognition; regulatory bodies try to retain control of the growing threat of bioterrorism and drug counterfeiting, and prices have been driven down by competition from generic drug sales and the increased negotiating power of managed-care providers.

With companies under more pressure than ever before to manage regulatory compliance, increase productivity and drive profit, the pharmaceutical supply chain has inevitably come under the spotlight. Recent studies (Streamlining Pharmaceutical Manufacturing and Distribution While Preparing for a More Complex Future – IBM Business Consulting Services whitepaper) have shown that supply chain operations can cost over one third of revenues and require about fifty per cent of total head count. Furthermore, one of the main reasons for drugs not launching on time is the readiness of the supply chain.

To keep pace with such a competitive and challenging market, pharmaceutical companies can no longer afford to carry the inefficiencies that have too often characterised the manufacturing supply chain. New and innovative ways of streamlining operations and improving control over process efficiency are required to ensure a more accurate and responsive supply chain.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Greg Tanner, Managing Director of Vocollect Europe, joined the company to expand its presence throughout Europe, the Middle East and Africa. He has a long career in international business development at the General Manager level, with experience in both direct and indirect sales organisations. Previously, Greg was Director of Channel Sales for Datalogic SpA, the European leader in barcode scanners and portable computers. As Managing Director for Zebra Technologies, the barcode printer manufacturer, he established Zebra Technologies Europe and opened the company’s first European facility in 1991. Greg is also a Member of the Board of AIM UK, the Trade Association for the Auto-ID industry.
spacer
Greg Tanner
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

LPS Industries Announces New Cleanroom Certification with State-of-the-Art Equipment Technology

Moonachie, NJ -- (ReleaseWire) -- 06/02/2021 -- LPS Industries, Moonachie NJ, (www.lpsind.com), a vertically integrated flexible packaging manufacturer, announced the certification of its new Class 100,000 cleanroom. Madeleine D. Robinson, CEO of LPS Industries, stated, "We're excited to announce our brand-new Class 100,000 certified cleanroom facility, providing unprinted and custom printed flexible packaging roll stock for the food and medical markets. These customers must meet highly exacting standards, and this cleanroom ensures that we can help them achieve the quality required."
More info >>

White Papers

What Your Clinical Study Design Reveals About Your Clinical Packaging Needs

PCI Pharma Services

As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >>

 
Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement